Rapidly-mixing Dantrium IV approved for malignant hyperthermia (MH) emergency
JHP Pharmaceuticals announced that the FDA has approved its rapidly-mixing formulation of Dantrium IV (dantrolene sodium for injection), designed to save time and effort during the emergency treatment...
View ArticleAHA: Device Uses Heartbeats to Power Pacemaker
(HealthDay News) – An experimental device about half the size of the batteries currently used in implantable devices can harness enough energy from a beating heart to generate adequate power to run a...
View ArticleLenvima Now Available Through Specialty Pharmacies
Eisai announced that Lenvima (lenvatinib) is now available through two specialty pharmacies, Accredo and Biologics Inc. for the treatment of locally recurrent or metastatic, progressive, radioactive...
View ArticleFDA Approves New Combination Therapy for Type 2 Diabetes
The Food and Drug Administration (FDA) has approved Qternmet XR (AstraZeneca) as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus (T2DM). Qternmet XR...
View ArticleNovember 2021: 5 Notable Drug Approvals
The new approvals include Besremi, Fyarro, Livtencity, Voxzogo, and Vuity.
View ArticleDecember 2021: 5 Notable Drug Approvals
Review the December 2021 notable drug approvals.
View ArticleFebruary 2022: 5 Notable Drug Approvals
Review the February 2022 notable drug approvals.
View Article--- Article Not Found! ---
*** *** *** RSSing Note: Article is missing! We don't know where we put it!!. *** ***
View Article--- Article Not Found! ---
*** *** *** RSSing Note: Article is missing! We don't know where we put it!!. *** ***
View ArticleRapidly-mixing Dantrium IV approved for malignant hyperthermia (MH) emergency
JHP Pharmaceuticals announced that the FDA has approved its rapidly-mixing formulation of Dantrium IV (dantrolene sodium for injection), designed to save time and effort during the emergency treatment...
View Article
More Pages to Explore .....